Skip to main content
SpringerLink
Log in

Pyoderma gangrenosum in the genital area: successful treatment using adalimumab

  • Correspondence
  • Published:
European Journal of Dermatology

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Ormerod AD, Thomas KS, Craig FE, et al. Comparison of the two most commonly used treatments for pyoderma gangrenosum: results of the STOP GAP randomised controlled trial. BMJ 2015; 350: 2958.

    Article  Google Scholar 

  2. Satoh M, Yamamoto T. Genital pyoderma gangrenosum: report of two cases and published work review of Japanese cases. J Dermatol 2013; 40: 840–3.

    PubMed  Google Scholar 

  3. Al Ghazal P, Herberger K, Schaller J, et al. Associated factors and comorbidities in patients with pyoderma gangrenosum in Germany: a retrospective multicentric analysis in 259 patients. Orphanet J Rare Dis 2013; 8:136.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Braswell SF, Kostopoulos TC, Ortega-Loayza AG. Pathophysiology of pyoderma gangrenosum (PG): an updated review. J Am Acad Dermatol 2015; 73: 691–8.

    Article  PubMed  CAS  Google Scholar 

  5. Quist SR, Kraas L. Treatment options for pyoderma gangrenosum. J Dtsch Dermatol Ges 2017; 15: 34–40.

    Google Scholar 

  6. Marzano AV, Ishak RS, Lazzari R, Polloni I, Vettoretti S, Crosti C. Vulvar pyoderma gangrenosum with renal involvement. Eur J Dermatol 2012; 22: 537–9.

    PubMed  Google Scholar 

  7. Sharon V, Burrall B, Patel F, et al. Multimodal therapy of idiopathic pyoderma gangrenosum. Dermatol Online J 2014; 15:20.

    Google Scholar 

  8. Hinterberger L, Müller CS, Vogt T, Pföhler C. Adalimumab: a treatment option for pyoderma gangrenosum after failure of systemic standard therapies. Dermatol Ther (Heidelb) 2012; 2:6.

    Article  Google Scholar 

  9. Marzano AV, Cugno M, Trevisan V, et al. Role of inflammatory cells, cytokines and matrix metalloproteinases in neutrophil-mediated skin diseases. Clin Exp Immunol 2010; 162: 100–7.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  10. Marzano AV, Fanoni D, Antiga E, et al. Expression of cytokines, chemokines and other effector molecules in two prototypic autoinflammatory skin diseases, pyoderma gangrenosum and Sweet’s syndrome. Clin Exp Immunol 2014; 178: 48–56.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Dermatology, Department of Specialistic, Clinical and Experimental Medicine, University of Bologna, Bologna, Italy

    Federico Bardazzi, Michela Magnano, Vera Tengattini & Camilla Loi

Authors
  1. Federico Bardazzi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michela Magnano
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Vera Tengattini
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Camilla Loi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michela Magnano.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bardazzi, F., Magnano, M., Tengattini, V. et al. Pyoderma gangrenosum in the genital area: successful treatment using adalimumab. Eur J Dermatol 28, 263–264 (2018). https://doi.org/10.1684/ejd.2018.3224

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1684/ejd.2018.3224

Search

Navigation